Outcome of sustained virological responders with histologically advanced chronic hepatitis C
Publication Type:
Journal Article
Source:
Hepatology, Volume 52, Issue 3, p.833-844 (2010)
Keywords:
Adult,
analysis,
Antiviral Agents,
California,
Carcinoma,
Carcinoma,Hepatocellular,
Cohort Studies,
diagnosis,
Disease,
Disease Progression,
drug therapy,
epidemiology,
Female,
Fibrosis,
Follow-Up Studies,
hepatitis,
Hepatitis C,
Hepatitis C,Chronic,
Humans,
interferon,
Interferon Alfa-2a,
Interferon-alpha,
Laboratories,
Liver,
Liver Neoplasms,
Liver Transplantation,
Male,
Middle Aged,
Morbidity,
Mortality,
Multicenter Studies,
nonresponder,
pathology,
Patients,
peginterferon,
Polyethylene Glycols,
Prognosis,
Prospective Studies,
Proteins,
Recombinant Proteins,
Recurrence,
Research,
Research Support,
Retrospective Studies,
Ribavirin,
Risk,
Risk Factors,
Severity of Illness Index,
Survival Rate,
SVR,
therapeutic use,
therapy,
Time,
transplantation,
Treatment Outcome,
United States
